Responses
Regular and Young Investigator Award Abstracts
Combination Immunotherapies
871 Combining KRASG12C(ON) inhibitor with SHP2 and/or immune checkpoint blockade to overcome adaptive resistance and enhance anti-tumour immunity in lung cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.
